Search results for "ONSET"

showing 10 items of 496 documents

Age at diagnosis is an important prognostic factor in Philadelphia-negative Myeloproliferative Neoplasms

2019

Oncologymedicine.medical_specialtyPrognostic factorPrognosiMEDLINEAge at diagnosisPhiladelphia chromosomeMyeloproliferative DisordersInternal medicinemedicineBiomarkers TumorHumansAge FactorPhiladelphia ChromosomeAge of OnsetMyeloproliferative DisorderPhiladelphia negativeMyeloproliferative Disordersbusiness.industryAge FactorsHematologyGeneral Medicinemedicine.diseasePrognosisAge of onsetbusinessHuman
researchProduct

Dosing fentanyl buccal tablet for breakthrough cancer pain: dose titration versus proportional doses.

2012

Abstract OBJECTIVES: The aim of this study was to compare the efficacy and safety of doses of fentanyl buccal tablet (FBT) proportional to doses of opioids used for background analgesia versus dose titration starting with the minimal dose for the management of breakthrough cancer pain (BTcP). METHODS: A total of 82 cancer patients with BTcP who were receiving strong opioids in doses of at least 60 mg of oral morphine equivalents and having acceptable background analgesia, were selected for a multicenter unblinded study. Forty-one patients were randomized to receive FBT in doses proportional to the daily opioid doses for four consecutive episodes of BTcP (group P). Forty-one patients underwe…

OralMaleDose titrationfentanyl buccal tabletAdministration OralOpioidDosing fentanylSettore MED/42 - Igiene Generale E ApplicataDose titrationlaw.inventionDose-Response RelationshipRandomized controlled triallawNeoplasmsFentanyl Buccal TabletMedicineHumansRapid onset opioidsDrug Dosage CalculationsCancer painAgedPain MeasurementAnalgesicsDose-Response Relationship DrugBreakthrough pain; Cancer pain; Dose titration; Fentanyl buccal tablet; Rapid onset opioids; Administration Oral; Aged; Analgesics Opioid; Breakthrough Pain; Dose-Response Relationship Drug; Female; Fentanyl; Humans; Male; Middle Aged; Neoplasms; Pain Measurement; Tablets; Titrimetry; Drug Dosage Calculations; Medicine (all)business.industryMedicine (all)Breakthrough PainTitrimetryCancerGeneral MedicineBuccal administrationfentanyl buccal tablet; breakthrough cancer pain; randomized clinical trialMiddle Agedmedicine.diseaserandomized clinical trialAnalgesics OpioidFentanylbreakthrough cancer painOpioidAnesthesiaAdministrationFemaleDrugbusinessCancer painmedicine.drugTabletsCurrent medical research and opinion
researchProduct

Late-Onset Globoid Cell Leukodystrophy: Unusual Ultrastructural Pathology and Subtotal β-Galactocerebrosidase Deficiency

1990

An 11-year-old girl was found to have severely reduced β-galactocerebrosidase activity as evidence of late-onset globoid cell leukodystrophy, while her mother had almost normal enzyme activity in circulating white blood cells. Clinically, the patient showed a remitting course marked by seizures, ataxia, white-matter disease on computed tomographic scan, and reduced conduction velocities of peripheral nerves. Symptoms improved somewhat around the age of 10 years. Two sural nerve biopsies, performed 6 years apart, disclosed a demyelinating neuropathy. By electron microscopy, membrane-bound vacuolar lysosomes in Schwann cells of myelinated axons, unlike the typical needlelike inclusions seen …

Pathologymedicine.medical_specialtyAtaxiaAdolescentBiopsyCellSural nerveBiologyUltrastructural Pathology03 medical and health sciences0302 clinical medicineSural Nerve030225 pediatricsBiopsymedicineHumansChildMyelin SheathInclusion Bodiesmedicine.diagnostic_testLeukodystrophymedicine.diseaseAxonsLeukodystrophy Globoid CellMicroscopy Electronmedicine.anatomical_structureLate-Onset Globoid Cell LeukodystrophyChild PreschoolPediatrics Perinatology and Child HealthFemaleSchwann CellsNeurology (clinical)medicine.symptom030217 neurology & neurosurgeryβ galactocerebrosidaseFollow-Up StudiesGalactosylceramidaseJournal of Child Neurology
researchProduct

Increased Frequency of Migraine in Narcoleptic Patients: A Confirmatory Study

2003

Previously we have reported an increased prevalence of migraine in narcoleptic patients. Because of the theoretical and clinical implications of this finding we recruited an independent new study sample of 100 patients with proven narcolepsy and conducted a structured 26-item interview based on the international diagnostic criteria for headache disorders, the Kiel Headache Questionnaire. Narcolepsy symptoms were measured by means of the Stanford Centre for Narcolepsy Sleep Inventory. Migraine prevalence was twofold to fourfold increased in the narcoleptic patients and amounted to 44.4% in women and 28.3% in men. The onset of narcolepsy symptoms was 12.3 ± 11.4 years before the onset of mig…

Pediatricsmedicine.medical_specialtyCataplexyCross-sectional studybusiness.industryGeneral Medicinemedicine.diseaseComorbidityMigrainemedicineNeurology (clinical)Headache DisordersAge of onsetmedicine.symptomPsychiatrybusinessBody mass indexNarcolepsyCephalalgia
researchProduct

Epigenetics in spine curvature disorders

2022

Abstract Scoliosis is a three-dimensional (3D) structural deformity of the spine with a radiological lateral Cobb angle of ≥ 10°. Several classification systems exist, dividing different types regarding the age of onset or the type of etiology. The minority of cases are secondary to congenital, syndromic of neuromosucular diseases. Most of the cases are classified “idiopathic” due to unknown etiology. These were formally divided by the age of onset into “Infantile Idiopathic Scoliosis” (0–3 years), “Juvenile Idiopathic Scoliosis” (JIS—4–10 years), and “Adolescent Idiopathic Scoliosis” (AIS → 10 years). Since the initiative of the Scoliosis Research Society in 2014 all kind of scoliosis with…

Pediatricsmedicine.medical_specialtyCobb anglebusiness.industryOsteoporosisScoliosismedicine.diseasePrecision medicinemedicineDeformityEtiologyEpigeneticsmedicine.symptomAge of onsetbusiness
researchProduct

Mucopolysaccharidosis Type VII (Sly disease) survivors

2013

treatment. Onset of neurological symptoms at age 8 and in adolescence. Pair 4: L.M. died at age 5 months due to liver failure. P.M. (7 years): earlyinfantile form, despite treatment start at age 2 progressive neurological deterioration. Pair 5: R.K.: late-infantile form, untreated, died at age 9 due to progressive neurological involvement. M.K.: late infantileform, start of treatment at age 5, died at age 13 due to epileptic encephalopathy. These cases reveal that disease onset and progression in siblings with NPC vary, and that miglustat can slow disease progression.

Pediatricsmedicine.medical_specialtyDisease onsetbusiness.industryEndocrinology Diabetes and MetabolismEpileptic encephalopathyMucopolysaccharidosisLiver failuremedicine.diseaseBiochemistryEndocrinologyMiglustatGeneticsmedicineSly diseaseSlow disease progressionbusinessMolecular Biologymedicine.drugMolecular Genetics and Metabolism
researchProduct

Clinical and Genetic Aspects of Juvenile Onset Pompe Disease

2021

AbstractLittle is known about clinical symptomatology and genetics of juvenile onset Pompe disease (JOPD). The aims of this study were to analyze how these children are diagnosed, what clinical problems they have, and how phenotype is related to genotype. To accomplish this, we analyzed retrospectively data of 34 patients diagnosed after their first and before completion of their 18th birthday. Median age at diagnosis was 3.9 (range 1.1–17) years. Eight patients (23.5%) developed initial symptoms in the first year, 12 (35%) between 1 and 7 years, and 6 (18%) thereafter. Eight (23.5%) had no clinical symptoms at the time of diagnosis. Indications for diagnostics were a positive family histor…

Pediatricsmedicine.medical_specialtyGeneralized muscle weaknessDisease03 medical and health sciences0302 clinical medicineGenotypeHumansMedicineFamily historyRetrospective Studies030304 developmental biology0303 health sciencesGlycogen Storage Disease Type IIbusiness.industryHypertrophic cardiomyopathyMuscle weaknessalpha-GlucosidasesGeneral Medicinemedicine.disease3. Good healthPhenotypeJuvenile onsetMutationPediatrics Perinatology and Child HealthFailure to thriveNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgeryNeuropediatrics
researchProduct

The Prevalence of Glaucoma in Young People.

2017

BACKGROUND Earlier information on the prevalence of glaucoma among children in Germany was based solely on estimates. Reported values for congenital glaucoma range from 1 in 10 000 to 1 in 68 000 depending on ethnic origin. The estimate for juvenile glaucoma is 1 in 44 000. METHODS The Gutenberg Health Study is a populationbased, prospective, monocentric cohort study with 15 010 participants aged 35 to 74. To determine the history-based prevalence of childhood glaucoma, participants were asked about the diagnosis of glaucoma, any operations for glaucoma that were performed, regular use of drugs for glaucoma, and the age of onset of glaucoma. The affected individuals were classified in four …

Pediatricsmedicine.medical_specialtyIntraocular pressureOpen angle glaucomagenetic structuresbusiness.industryCross-sectional studyGlaucomaGeneral Medicinemedicine.diseaseeye diseases03 medical and health sciences0302 clinical medicineCohort030221 ophthalmology & optometrymedicinesense organsAge of onsetProspective cohort studybusiness610 Medicine & health030217 neurology & neurosurgeryCohort study
researchProduct

Commentary: Anderson‐Fabry Disease: A Rare Cause of Levodopa‐Responsive Early Onset Parkinsonism

2021

NA

Pediatricsmedicine.medical_specialtyLevodopaAnderson-Fabry DiseaseNeurologybusiness.industrymedicineAnderson-Fabry disease early onset parkinsonism levodopa response lysosomal storage diseasesNeurology (clinical)Early onset parkinsonismbusinessCase Reports and Commentariesmedicine.drugMovement Disorders Clinical Practice
researchProduct

Migraine in Children Under 7 Years of Age: a Review

2020

Purpose of review: Despite the accumulation of a significant amount of data on pediatric headache, few studies have been conducted on its occurrence in children under 7 years of age. Within primary headaches in this age, migraine especially, turns out to be a disorder affecting up to 4% of the general population. An underestimate of its true prevalence can be due to lack of specific diagnostic markers, the frequent difficulty of describing pain in childhood, and the necessity of reliable parents’ reports. Thus, migraine in children under 7 years of age represents an important challenge for clinicians. The objective of this manuscript is to provide a comprehensive review of epidemiologic, cl…

Pediatricsmedicine.medical_specialtyMigraine DisordersPain medicinePopulation03 medical and health sciences0302 clinical medicinePrimary headacheRisk Factors030202 anesthesiologyHumansMedicineAge of OnsetChildeducationChildrenMigraineEmbryo-fetal developmenteducation.field_of_studyPreschoolersbusiness.industryAge FactorsBrainGeneral MedicinePediatric headachemedicine.diseasePediatric headacheNatural historyAnesthesiology and Pain MedicineMigraineChild PreschoolAnticipation (genetics)Neurology (clinical)business030217 neurology & neurosurgeryPediatric populationCurrent Pain and Headache Reports
researchProduct